TRPML-1 Dysfunction and Renal Tubulopathy in Mucolipidosis Type IV
Journal of the American Society of Nephrology · 2025
DOI: 10.1681/asn.0000000567 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2025. Verfasst von Giuseppina Grieco und 19 weiteren Autor:innen. Beteiligte Einrichtung: Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy. Hauptthemen laut MEDLINE: Mucolipidoses, Transient Receptor Potential Channels, Kidney. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fondazione Telethon, Million dollar bike ride grant program, Fondazione Telethon, Million dollar bike ride grant program.
Abstract (Originalsprache)
Key Points Lack of transient receptor potential cation channel (TRPML-1) causes tubulopathy. Only adults affected of mucolipidosis type IV present kidney damage signs, including lower eGFR and higher levels of BUN/creatine in blood and proteinuria. TRPML-1 deficiency links lysosomal and autophagic dysfunction with inflammation in mucolipidosis type IV kidney disease.
Background
Loss-of-function mutations in the lysosomal channel transient receptor potential cation channel (TRPML-1) cause mucolipidosis type IV (MLIV), a rare lysosomal storage disease characterized by neurological defects, progressive vision loss, and achlorhydria. Recent reports have highlighted kidney disease and kidney failure in patients with MLIV during the second to third decade of life; however, the molecular mechanisms driving kidney dysfunction remain poorly understood.
Methods
A cross-sectional review of medical records from 21 patients with MLIV (ages 3–43 years) was conducted to assess kidney function impairment. In addition, we examined the kidney phenotype of MLIV mice at various ages, along with human kidney cells silenced for TRPML-1 and primary tubular cells from wild-type and MLIV mice. Immunohistology and cell biology approaches were used to phenotype nephron structure, the endolysosomal compartment, and inflammation. Kidney function was assessed through proteomic analysis of mouse urine and in vivo kidney filtration measurements.
Results
Of the 21 patients with MLIV, only adults were diagnosed with stage 2–3 CKD. Laboratory abnormalities included lower eGFR and higher levels BUN/creatine in blood and proteinuria. In MLIV mice, we observed significant alterations in endolysosomal morphology, function, and impaired autophagy in proximal and distal tubules. This led to the accumulation of megalin (LRP2) in the subapical region of proximal tubular cells, indicating a block in apical receptor–mediated endocytosis. In vivo and in vitro experiments confirmed reduced fluid-phase endocytosis and impaired uptake of ligands, including β -lactoglobulin, transferrin, and albumin in MLIV proximal tubular cells. Urine analysis revealed tubular proteinuria and enzymuria in mice with MLIV. In addition, early-stage disease was marked by increased inflammatory markers, fibrosis, and activation of the proinflammatory transcription factor NF-κB, coinciding with endolysosomal defects. Importantly, adeno-associated viral–mediated TRPML-1 gene delivery reversed key pathological phenotypes in MLIV mice, underscoring TRPML-1's critical role in kidney function.
Conclusions
Our findings link TRPML-1 dysfunction to the development of kidney disease in MLIV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.
- Department of Neurology, Massachusetts General Hospital Center for Genomic Medicine, Harvard Medical School, Boston, Massachusetts.
- Department of Medical Translational Sciences, University of Campania "Luigi Vanvitelli," Naples, Italy.
- Institute of Molecular Biology and Genetics, Biogem, Ariano Irpino, Italy.
- Institute for Genetic and Biomedical Research, National Research Council (CNR), Milan, Italy.
- Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.
ORCID-Profile: Giuseppina Grieco, Antonio Miele, Luciano D'Apolito, Miriam Aurilia, Leopoldo Staiano, Marcella Cesana, Patricia Musolino, Francesco Trepiccione, Yulia Grishchuk, Diego Luis Medina
Förderung
- Fondazione Telethon, Million dollar bike ride grant program
- Fondazione Telethon
- Million dollar bike ride grant program
Zitieren
APA
Grieco, G., Montefusco, S., Nusco, E., Capuozzo, A., Cervellini, F., Polishchuk, E., Bishop, M., Miele, A., D'Apolito, L., La Vecchia, C., Aurilia, M., Schiavo, M., Staiano, L., Cesana, M., Oberman, R., Lynch, A. V., Musolino, P., Trepiccione, F., Grishchuk, Y., & Medina, D. L. (2025). TRPML-1 Dysfunction and Renal Tubulopathy in Mucolipidosis Type IV. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000000567
Vancouver
Grieco G, Montefusco S, Nusco E, Capuozzo A, Cervellini F, Polishchuk E, et al. TRPML-1 Dysfunction and Renal Tubulopathy in Mucolipidosis Type IV. Journal of the American Society of Nephrology. 2025. doi:10.1681/asn.0000000567
BibTeX
@article{Grieco2025,
author = {Grieco, Giuseppina and Montefusco, Sandro and Nusco, Edoardo and Capuozzo, Antonella and Cervellini, Francesca and Polishchuk, Elena and Bishop, Martha and Miele, Antonio and D'Apolito, Luciano and La Vecchia, Claudia and Aurilia, Miriam and Schiavo, Michela and Staiano, Leopoldo and Cesana, Marcella and Oberman, Rebecca and Lynch, Anna V and Musolino, Patricia and Trepiccione, Francesco and Grishchuk, Yulia and Medina, Diego Luis},
title = {TRPML-1 Dysfunction and Renal Tubulopathy in Mucolipidosis Type IV},
journal = {Journal of the American Society of Nephrology},
year = {2025},
doi = {10.1681/asn.0000000567}
}
EUVIMED